Moderna to cut costs, trim pipeline in R&D revamp

Sep 12, 2024  · Dive Brief: Moderna will cut R&D spending by 20% and trim its pipeline as part of a strategic overhaul that will shift its research focus and put more resources into products that …


Install CouponFollow Chrome Extension   CouponFollow Extension

20%
OFF

Moderna To Cut Costs, Trim Pipeline In R&D Revamp

2 weeks from now

Sep 12, 2024  · Dive Brief: Moderna will cut R&D spending by 20% and trim its pipeline as part of a strategic overhaul that will shift its research focus and put more resources into products that …

biopharmadive.com

$1
OFF

Moderna Targets $1.1B In R&D Spending Cuts, Drops 5 Programs …

2 weeks from now

Sep 12, 2024  · Cutting the budget will take time, with Moderna forecasting R&D spending of $4.2 billion to $4.5 billion in 2025. The biotech disclosed a raft of pipeline changes as part of the …

fiercebiotech.com

$1
OFF

Moderna Shares Plunge On Plans To Cut $1.1 Billion In Costs, Launch …

2 weeks from now

Sep 12, 2024  · Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.

cnbc.com

20%
OFF

MRNA To Cut R&D Costs, Stops Five Pipeline Programs

2 weeks from now

Sep 13, 2024  · As part of its strategic prioritization, Moderna aims to cut its R&D expenses by 20% over the next four years. It decides to end five pipeline programs to save costs.

yahoo.com

$3
OFF

Moderna's Stock Slides As It Slashes Research Spending, Trims Pipeline

2 weeks from now

Sep 12, 2024  · In early August, Moderna's stock suffered its biggest-ever one-day decline after the company cut its full-year 2024 sales guidance to a range of $3 billion to $3.5 billion, down …

morningstar.com

$1
OFF

Moderna Will Cut $1.1bn Off Its Annual R&D Spend

2 weeks from now

Jan 27, 2025  · Moderna is showcasing its R&D pipeline to investors today, but the headline news is a decision to cut its R&D spend by a massive $1.1 billion a year from 2027, reversing years …

pharmaphorum.com

$1
OFF

Moderna Expects Lower Annual Sales, Expands Cost-Cutting …

2 weeks from now

Jan 13, 2025  · Moderna targets ten product approvals by 2027 while cutting R&D costs by $1.1 billion. FY2024 revenue reached $3 billion-$3.1 billion, with $9.5B in cash reserves.

benzinga.com

$1
OFF

Moderna Stock Drops On Plans To Cut $1.1B In R&D Costs - MSN

2 weeks from now

Key Takeaways Moderna shares fell Thursday morning after the COVID vaccine maker announced plans to trim its research and development pipeline to cut costs.The company said …

msn.com

$1
OFF

Moderna Cuts Five Programmes To Save $1.1bn In R&D Costs

2 weeks from now

Sep 12, 2024  · Moderna will cut five clinical programmes amid plans to reduce $1.1bn of R&D costs following years of declining revenues. ... Moderna also said it plans to break even on an …

yahoo.com

$1
OFF

Moderna To Cut R&D Expenses By $1.1B | Pharma Manufacturing

2 weeks from now

Sep 12, 2024  · This week, Moderna outlined its R&D progress and cost-cutting strategy, aiming for 10 product approvals by 2027 while reducing expenses. To streamline operations, …

pharmamanufacturing.com

$1
OFF

Moderna Revamps R&D Strategy With $1.1B Cuts And Pipeline …

2 weeks from now

Sep 13, 2024  · Moderna has announced a significant reduction in its research and development (R&D) budget by $1.1 billion, aiming to streamline its operations and enhance profitability. …

talk.bio

$2
OFF

Moderna Outlines Pipeline Progress, Cost Cuts - Investing.com

2 weeks from now

Sep 12, 2024  · In the realm of financial analysis, Brookline Capital Markets maintained a Buy rating on Moderna, projecting the COVID-19 vaccines to generate $2.7 billion in sales for …

investing.com

$1
OFF

JPM25: Moderna Slashes Guidance, Plots $1B In Cost Cuts This Year …

2 weeks from now

Jan 13, 2025  · The company has reduced its revenue guidance for 2025, as well, forecasting sales to land between $1.5 billion and $2.5 billion this year. The big biotech previously hoped …

fiercepharma.com

$1
OFF

Moderna Stock Drops On Plans To Cut $1.1B In R&D Costs

2 weeks from now

Moderna CEO Stephane Bancel at the grand opening of the company's new headquarters outside Kendall Square on June 26, 2024. Moderna shares fell after announcing plans to trim its …

flipit.money

20%
OFF

Biotech Advances: Moderna To Cut Costs And Trim Pipeline In R&D …

2 weeks from now

Sep 12, 2024  · Biotech firm Moderna is implementing significant changes as part of its R&D revamp. The company plans to reduce research spending by 20% and eliminate five early …

livarava.com

$1
OFF

Moderna Plans $1.1B In R&D And Program Cuts, Delays Break-even …

2 weeks from now

Sep 12, 2024  · Stéphane Bancel has relented to Wall Street’s desire for cost-cutting and reining in Moderna’s pipeline. To kick off its annual R&D day in New York, Moderna said Thursday that it ...

endpts.com

FAQs about Moderna to cut costs, trim pipeline in R&D revamp Coupon?

Will Moderna cut costs by $1.1 billion by 2027?

Moderna said it expects the moves to lower expenses by $1.1 billion by 2027. Moderna (MRNA) shares tumbled in pre-market trading Thursday as the company said it plans to cut costs and suspend or end development of some products as it focuses on later-stage trials. ...

How much will Moderna spend on R&D in 2027?

In September, Moderna unveiled key updates at its annual R&D Day by reducing annual R&D spending by $1.1 billion by 2027, enabling a focus on ten prioritized products. The company expects R&D expenses to fall from $4.8 billion in 2024E to $3.6 billion—$3.8 billion in 2027. ...

Will Moderna cut 5 clinical programmes to save $1.1bn in R&D costs?

"Moderna cuts five programmes to save $1.1bn in R&D costs" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. Moderna will slash five clinical programmes but says it remains on track for ten product approvals in the next three years. ...

Why did Moderna cut 5 clinical programmes?

Moderna will cut five clinical programmes amid plans to reduce $1.1bn of R&D costs following years of declining revenues. ...

How did Moderna perform in 3rd quarter?

Moderna reported third-quarter revenue of $1.83 billion, compared with $1.83 billion a year earlier, beating the consensus of $1.25 billion. The company attributed the growth to higher sales in the U.S. market following the earlier launch of the updated COVID-19 vaccine. ...

How much money did Moderna make in FY2024?

Moderna targets ten product approvals by 2027 while cutting R&D costs by $1.1 billion. FY2024 revenue reached $3 billion-$3.1 billion, with $9.5B in cash reserves. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension